Foghorn Therapeutics (FHTX) Amortizatization of Intangibles (2020 - 2026)

Foghorn Therapeutics (FHTX) recorded quarterly Amortizatization of Intangibles of $388000.0 in Q1 2026, up 26.8% quarter-over-quarter from $306000.0 in Q4 2025, and down 52.57% on a YoY basis from $818000.0 in Q1 2025.

Foghorn Therapeutics (FHTX) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends

Foghorn Therapeutics' Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $388000.0 for Q1 2026.

  • In Q1 2026, Amortizatization of Intangibles fell 52.57% year-over-year to $388000.0; the TTM figure through Mar 2026 stood at $1.5 million (down 69.33% YoY), while the FY2025 annual figure was $1.9 million, down 58.25% from the prior year.
  • Amortizatization of Intangibles was $388000.0 for Q1 2026 at Foghorn Therapeutics, up from $306000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $1.8 million in Q3 2024 to a low of -$38000.0 in Q1 2022.
  • Historically, Amortizatization of Intangibles has averaged $639588.2 across 5 years, with a median of $554000.0 in 2024.
  • Biggest YoY gain for Amortizatization of Intangibles was 6540.0% in 2022; the steepest drop was 392.31% in 2022.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $574000.0 in 2022, then slipped by 13.76% to $495000.0 in 2023, then surged by 216.97% to $1.6 million in 2024, then sank by 80.5% to $306000.0 in 2025, then increased by 26.8% to $388000.0 in 2026.
  • The last three Amortizatization of Intangibles figures came in at $388000.0 (Q1 2026), $306000.0 (Q4 2025), and $356000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 13,267.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Foghorn Therapeutics 282.33 Mn 193.42 Mn - 388,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 388,000.00
Mar 31, 2026 388,000.00
Dec 31, 2025 306,000.00
Dec 31, 2025 306,000.00
Sep 30, 2025 356,000.00
Sep 30, 2025 356,000.00
Jun 30, 2025 446,000.00
Jun 30, 2025 446,000.00
Mar 31, 2025 818,000.00
Mar 31, 2025 818,000.00
Dec 31, 2024 1.57 Mn
Dec 31, 2024 1.57 Mn
Sep 30, 2024 1.79 Mn
Sep 30, 2024 1.79 Mn
Jun 30, 2024 705,000.00
Jun 30, 2024 705,000.00
Mar 31, 2024 554,000.00
Mar 31, 2024 554,000.00
Dec 31, 2023 495,000.00
Dec 31, 2023 495,000.00